Cancer Immunotherapy

The main aim of integrating structural biology data into cancer research is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Today’s most encouraging cancer therapy is immunotherapy. These treatments stimulate the patient’s immune system to destroy his/her cancer cells. Some drugs recognize specific molecules on the surface of cancer cells while others can bind to immune cells to help them kill cancer cells. This can be done mostly in two ways such as

  •    Stimulating your own immune system to work harder or smarter to attack cancer cells
  •   Giving you immune system components, such as man-made immune system proteins

Consequently, many Structural Biologists are conducting cancer research, to speed-up the process of understanding the mechanism of biomolecules in order to improve the newer cancer therapies

  • Molecular mechanism of Cancer Initiation
  • Cancer Vaccines
  • Non-specific Immunotherapies
  • Oncologic drug targets

Related Conference of Cancer Immunotherapy

February 12-13, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-18, 2018

34th International Conference on Chemical Biology & Radiation Therapy

San Diego, California
July 23-24 , 2018

International Conference of Forensic Research & Technology

Melbourne , Australia
August 06-07, 2018

International Conference on Structural Biology

Dubai, UAE
August 27-28, 2018

5th International Conference on Glycobiology

Toronto, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
September 10-11, 2018

International Conference on Nutritional Biochemistry

Prague, Czech Republic
October 17-18, 2018

2nd International Meeting on Global Proteomics Conference

Seoul ,South Korea
November 29-30, 2018

Bioinformatics Congress 2018

Dublin, Ireland

Cancer Immunotherapy Conference Speakers